Vision to see the ‘Invisible opportunity’
Caplin Point aims to create new niches in the markets of its presence. Looking ahead, we envisage implementing our unique business model to ensure that everyone in the market where Caplin is present enjoys access to quality medicines at affordable prices
Mission to address the pain of the poor
Innovate constantly to change the rules of the game and not merely compete in the game because it is innovation that distinguishes a leader from a follower
History of life on this planet is the history of rule breakers
Caplin Point was established in 1990 to manufacture a range of ointments, creams and other external applications. The Company was listed in 1994; the IPO proceeds were deployed in a manufacturing facility in Pondicherry. The promoters exposed their lives to physical risk when they ventured into war-affected countries more than two decades ago. The Company ventured into the emerging markets of West Africa, Latin America and The Caribbean to market finished formulations.
Management
Caplin Point is headed by Mr. C. C. Paarthipan (Chairman) and Dr. Sridhar Ganesan (Managing Director), who are supported by a competent managerial and technical team. The Board that leads the Company does not comprise any member of the promoter’s family apart from the Chairman.
Partner
To expand its presence in the area of global injectables, the Company attracted investments in its subsidiary company Caplin Steriles Limited (CSL) from Eight Roads Ventures India Ill LP and F-Prime Capital Partners Life Sciences Fund VI LP (Fidelity Group) through Compulsorily Convertible Preference Shares (CCPS) to be converted into equity shares of CSL based on agreed terms